Aleksandr Dolgoter

Title: Innovations in Cancer Treatment by Aleksandr Dolgoter

Introduction

Aleksandr Dolgoter is an innovative inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. His work focuses on developing advanced therapeutic solutions aimed at combating cancer through immunotherapy.

Latest Patents

Dolgoter holds a patent for a groundbreaking invention titled "Tumor cell vaccines." This patent presents an allogeneic whole cell cancer vaccine platform that includes compositions and methods for treating and preventing cancer. The disclosed compositions contain a therapeutically effective amount of cells from one or more cancer cell lines, which are modified to inhibit or reduce the expression of immunosuppressive factors and enhance the expression of immunostimulatory factors. Additionally, the vaccine includes tumor-associated antigens (TAAs), including mutated TAAs, derived from cancer cell lines that express a variety of tumor-associated antigens and neoantigens.

Career Highlights

Dolgoter's career is marked by his dedication to advancing cancer treatment methodologies. His innovative approach to vaccine development has the potential to significantly improve patient outcomes in cancer therapy. He is currently associated with Neuvogen, Inc., where he continues to work on pioneering cancer treatment solutions.

Collaborations

Throughout his career, Dolgoter has collaborated with notable professionals in the field, including Bernadette Ferraro and Todd Merrill Binder. These collaborations have further enriched his research and development efforts in cancer immunotherapy.

Conclusion

Aleksandr Dolgoter's contributions to cancer treatment through his innovative tumor cell vaccine patent exemplify the potential of immunotherapy in modern medicine. His work continues to inspire advancements in the fight against cancer.